I don't think that's a fair characterisation of the way in which medicines are made available in the national health service. There's a challenge here about saying, 'There's an unmet need', and 'How do we get an effective, licensed, safe product available on the national health service to do that?', and simply saying, 'The answer is to make cannabis available medicinally'. I'll come on to some of the challenges about that, but Sativex became available because it fulfilled all of those criteria: the safety and efficacy tests of licensing, and then, secondly, the medicine passed the rigorous appraisal process—